参考资料: http://engitix.com/engitix-signs-collaboration-and-licensing-agreement-with-takeda-to-develop-anti-fibrotic-therapies-in-advanced-liver-diseases/https://endpts.com/takeda-inks-up-to-500m-extra-cellular-matrix-biotech-for-nash/